ALSERES PHARMACEUTICALS INC /DE Retained Earnings
ALSERES PHARMACEUTICALS INC /DE had Retained Earnings of -$197.37 million as of 2012-03-31, per its 10-Q filed 2012-05-11.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent › Retained Earnings (Accumulated Deficit)
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2012-05-11
- 2012-03-31: Retained Earnings (Accumulated Deficit) -$197.37M.
- 2011-12-31: Retained Earnings (Accumulated Deficit) -$197.05M.
- 2011-09-30: Retained Earnings (Accumulated Deficit) -$196.25M.
- 2011-06-30: Retained Earnings (Accumulated Deficit) -$195.78M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2012-03-31 | -$197.37M 10-Q · filed 2012-05-11 |
| 2011-12-31 | -$197.05M 10-Q · filed 2012-05-11 |
| 2011-09-30 | -$196.25M 10-Q · filed 2011-11-10 |
| 2011-06-30 | -$195.78M 10-Q · filed 2011-08-11 |
| 2010-12-31 | -$194.17M 10-K · filed 2012-03-29 |